Development Level

Tbio 7 | 10,625
Tchem 1 | 1,890

Collection

Eligible non-olfactory GPCR Proteins 2 | 143

IMPC Term

abnormal behavior 1 | 226
abnormal coat appearance 1 | 25
abnormal coat/hair pigmentatio... 1 | 54
abnormal lens morphology 1 | 73
abnormal liver morphology 1 | 5
abnormal optic disc morphology 1 | 10
abnormal vibrissa morphology 1 | 17
abnormal whole-body plethysmog... 1 | 4
decreased IgE level 1 | 3
decreased body weight 1 | 174
decreased bone mineral content 1 | 157
decreased circulating chloride... 1 | 32
decreased circulating glucose ... 1 | 121
decreased vertical activity 1 | 22
hypoactivity 1 | 89
increased blood uric acid leve... 1 | 5
increased circulating alkaline... 1 | 119
increased circulating calcium ... 1 | 32
increased circulating chloride... 1 | 43
increased circulating sodium l... 1 | 71
increased erythrocyte cell num... 1 | 26
increased fasted circulating g... 1 | 68
increased hematocrit 1 | 36
increased hemoglobin content 1 | 45
increased monocyte cell number 1 | 27
male infertility 1 | 62
small testis 1 | 37
urinary bladder obstruction 1 | 2

Disease

Cryptorchidism 4 | 67
Infertility 2 | 163
Testicular cancer 2 | 24
osteosarcoma 2 | 7,933
Alzheimer's disease 1 | 644
Endometriosis 1 | 535
Hyperandrogenism 1 | 32
Hyperplasia 1 | 26
Hypogonadism 1 | 70
Hypospadias 1 | 65
Inguinal hernia 1 | 13
Klinefelter's syndrome 1 | 59
Leukemia, Lymphocytic, Acute, L1 1 | 11
Male infertility 1 | 170
Myocardial Ischemia 1 | 169
Peripartum cardiomyopathy 1 | 4
Pick disease 1 | 1,893
Prostatic Neoplasms 1 | 471
Robinow syndrome 1 | 12
Tick infestation 1 | 16
adrenocortical adenoma 1 | 134
adrenocortical carcinoma 1 | 1,427
astrocytic glioma 1 | 2,241
atypical teratoid / rhabdoid tumor 1 | 4,369
ependymoma 1 | 2,514
glioblastoma 1 | 5,572
lung adenocarcinoma 1 | 2,713
lung carcinoma 1 | 2,844
medulloblastoma 1 | 1,524
medulloblastoma, large-cell 1 | 6,234
non-small cell lung carcinoma 1 | 413
oligodendroglioma 1 | 2,849
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
posterior fossa group B ependymoma 1 | 1,530
primitive neuroectodermal tumor 1 | 3,031
psoriasis 1 | 6,685
tuberculosis and treatment for 6 months 1 | 686

Tissue

Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Nervous System 8 | 18,561
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444
Blood and immune system 7 | 17,995
Male tissues 7 | 17,969
Respiratory system 7 | 17,484

Target Family

GPCR 4 | 406
Non-IDG 4 | 11,971

Reactome Pathway

Relaxin receptors 8 | 8
Signal Transduction 2,516 | 2,516
Immune System 2,184 | 2,184
Metabolism 2,132 | 2,132
Gene Expression 1,755 | 1,755
Metabolism of proteins 1,545 | 1,545
Innate Immune System 1,376 | 1,376
Signaling by GPCR 1,330 | 1,330
Developmental Biology 1,029 | 1,029
GPCR downstream signaling 1,015 | 1,015
Post-translational protein mod... 1,005 | 1,005
Adaptive Immune System 939 | 939
Disease 856 | 856
Generic Transcription Pathway 852 | 852
Cytokine Signaling in Immune s... 804 | 804
Metabolism of lipids and lipop... 797 | 797
Vesicle-mediated transport 705 | 705
Hemostasis 669 | 669
Transmembrane transport of sma... 669 | 669
Membrane Trafficking 608 | 608
Cell Cycle 573 | 573
Axon guidance 542 | 542
Neutrophil degranulation 542 | 542
Signaling by Interleukins 501 | 501
Cell Cycle, Mitotic 471 | 471
Signalling by NGF 468 | 468
GPCR ligand binding 456 | 456
Gastrin-CREB signalling pathwa... 436 | 436
Class I MHC mediated antigen p... 431 | 431
Olfactory Signaling Pathway 430 | 430
Fc epsilon receptor (FCERI) si... 424 | 424
Cellular responses to stress 416 | 416
DAP12 interactions 410 | 410
Infectious disease 392 | 392
NGF signalling via TRKA from t... 379 | 379
Signaling by Rho GTPases 378 | 378
Signaling by PDGF 368 | 368
Diseases of signal transductio... 360 | 360
Signaling by EGFR 356 | 356
Transcriptional Regulation by ... 356 | 356
Metabolism of amino acids and ... 354 | 354
DAP12 signaling 347 | 347
Downstream signal transduction 344 | 344
Neuronal System 343 | 343
Organelle biogenesis and maint... 334 | 334
Signaling by VEGF 330 | 330
Signaling by SCF-KIT 328 | 328
Class A/1 (Rhodopsin-like rece... 322 | 322
VEGFA-VEGFR2 Pathway 322 | 322
FCERI mediated MAPK activation 317 | 317
Signaling by Insulin receptor 313 | 313
Antigen processing: Ubiquitina... 302 | 302
Extracellular matrix organizat... 292 | 292
Signaling by Type 1 Insulin-li... 291 | 291
Signaling by Wnt 291 | 291
IGF1R signaling cascade 290 | 290
IRS-related events triggered b... 290 | 290
Insulin receptor signalling ca... 289 | 289
Metabolism of carbohydrates 288 | 288
DNA Repair 286 | 286
IRS-mediated signalling 286 | 286
MAPK family signaling cascades 284 | 284
Signaling by the B Cell Recept... 283 | 283
Asparagine N-linked glycosylat... 282 | 282
SLC-mediated transmembrane tra... 280 | 280
Deubiquitination 278 | 278
Interferon Signaling 275 | 275
Platelet activation, signaling... 274 | 274
NCAM signaling for neurite out... 269 | 269
M Phase 267 | 267
Interleukin-3, 5 and GM-CSF si... 263 | 263
RET signaling 262 | 262
Signalling to ERKs 255 | 255
Interleukin-2 signaling 254 | 254
Immunoregulatory interactions ... 252 | 252
VEGFR2 mediated cell prolifera... 250 | 250
RHO GTPase Effectors 249 | 249
Signalling to RAS 248 | 248
Interleukin receptor SHC signa... 247 | 247
G alpha (i) signalling events 245 | 245
Signaling by Leptin 245 | 245
Fatty acid, triacylglycerol, a... 244 | 244
Prolonged ERK activation event... 244 | 244
MAPK1/MAPK3 signaling 243 | 243
Frs2-mediated activation 242 | 242
HIV Infection 242 | 242
ARMS-mediated activation 241 | 241
Signalling to p38 via RIT and ... 241 | 241
Chromatin modifying enzymes 237 | 237
Chromatin organization 237 | 237
GRB2 events in EGFR signaling 237 | 237
RAF/MAP kinase cascade 237 | 237
SHC1 events in EGFR signaling 237 | 237
SOS-mediated signalling 237 | 237
Processing of Capped Intron-Co... 235 | 235
Biological oxidations 215 | 215
Keratinization 213 | 213
Transmission across Chemical S... 210 | 210
rRNA processing 209 | 209
Ion channel transport 204 | 204
Ub-specific processing proteas... 203 | 203

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Insulin-like 3 INSL3 Tbio Non-IDG -2.36458 271.7 127
Relaxin receptor 1 RXFP1 Tbio GPCR -2.17733 168.6 199
Relaxin-3 RLN3 Tbio Non-IDG -1.83896 88.6 68
Relaxin receptor 2 RXFP2 Tbio GPCR -1.94619 81.2 200
Insulin-like peptide INSL5 INSL5 Tbio Non-IDG -1.35482 24.0 40
Relaxin-3 receptor 2 RXFP4 Tbio GPCR -1.11927 13.3 112
Relaxin-3 receptor 1 RXFP3 Tchem GPCR -1.60268 49.3 165
Prorelaxin H2 RLN2 Tbio Non-IDG -1.91344 85.9 181